An antihypertensive lactoferrin hydrolysate inhibits angiotensin I-converting enzyme, modifies expression of hypertension-related genes and enhances nitric oxide production in cultured human endothelial cells

Journal of Functional Foods

Volumn 12, Issue , 2015, Pages 45-54

  García Tejedor, Aurora ^a   Gimeno Alcañíz, José V ^a   Tavárez, Sandra ^b   Alonso, Eulalia ^b   Salom, Juan B ^c,d   Manzanares, Paloma ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

ACE inhibition; Endothelial cells; Lactoferrin hydrolysate; Nitric oxide; NOSTRIN; Transcriptomic analysis

Indexed keywords

EID: 84920749617     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.11.002     Document Type: Article

References (51)

1. Ajibola C.F., Fashakin J.B., Fagbemi T.N., Aluko R.E. Renin and angiotensin converting enzyme inhibition with antioxidant properties of African yam bean protein hydrolysate and reverse-phase HPLC-separated peptide fractions. Food Research International 2013, 52:437-444.
2. Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increase guanosine 3',5'-monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America 1977, 74:3203-3207.
3. Boelsma E., Kloek J. Lactotripeptides and antihypertensive effects: A critical review. The British Journal of Nutrition 2009, 101:776-786.
4. Brewster U.C., Perazella M.A. The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. The American Journal of Medicine 2004, 116:263-272.
5. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: Potential roles in cardiovascular and renal regulation. Endocrine Reviews 2003, 24:261-271.
6. Centeno J.M., Burguete M.C., Castelló-Ruiz M., Enrique M., Vallés S., Salom J.B., Torregrosa G., Marcos J.F., Alborch E., Manzanares P. Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction. Journal of Agricultural and Food Chemistry 2006, 54:5323-5329.
7. Chattopadhyay S., Santhamma K.R., Sengupta S., McCue B., Kinter M., Sen G.C., Sen I. Calmodulin binds to the cytoplasmic domain of angiotensin-converting enzyme and regulates its phosphorylation and cleavage secretion. The Journal of Biological Chemistry 2005, 280:33847-33855.
8. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:6368-6371.
9. Fernández-Musoles R., Castelló-Ruiz M., Arce C., Manzanares P., Ivorra M.D., Salom J.B. Antihypertensive mechanism of lactoferrin-derived peptides: Angiotensin receptor blocking effect. Journal of Agricultural and Food Chemistry 2014, 62:173-181.
10. Fernández-Musoles R., López-Díez J.J., Torregrosa G., Vallés S., Alborch E., Manzanares P., Salom J.B. Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction. Peptides 2010, 31:1926-1933.
11. Fernández-Musoles R., Manzanares P., Burguete M.C., Alborch E., Salom J.B. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats. Food Research International 2013, 54:627-632.
12. Fernández-Musoles R., Salom J.B., Martínez-Maqueda D., López-Díez J.J., Recio I., Manzanares P. Antihypertensive effects of lactoferrin hydrolysates: Inhibition of angiotensin- and endothelin-converting enzymes. Food Chemistry 2013, 139:994-1000.
13. Fitzgerald C., Mora-Soler L., Gallagher E., O'Connor P., Prieto J., Soler-Vila A., Hayes M. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmate. Journal of Agricultural and Food Chemistry 2012, 60:7421-7427.
14. Galle J., Zabel U., Hübner U., Hatzelmann A., Wagner B., Wanner C., Schmidt H.H.H.W. Effects of soluble guanylyl cyclase activator, TC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. British Journal of Pharmacology 1999, 127:195-203.
15. García-Redondo A.B., Roque F.R., Miguel M., López-Fandiño R., Salaices M. Vascular effects of egg white-derived peptides in resistance arteries from rats. Structure-activity relationships. Journal of the Science of Food and Agriculture 2010, 90:1988-1993.
16. García-Tejedor A., Sánchez-Rivera L., Castelló-Ruiz M., Recio I., Salom J.B., Manzanares P. Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: Gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition. Journal of Agricultural and Food Chemistry 2014, 62:1609-1616.
17. Geller D.A., Billiar T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Reviews 1998, 17:7-23.
18. Gotoh T., Mori M. Arginase II dowregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. The Journal of Cell Biology 1999, 144:427-434.
19. Guerreiro J.R., Lameu C., Oliveira E.F., Klitzke C.F., Melo R.L., Linares E., Augusto O., Fox J.W., Lebrun I., Serrano S.M.T., Camargo A.C.M. Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide. Role in arginine and nitric oxide production. The Journal of Biological Chemistry 2009, 284:20022-20033.
20. Hillmeister P., Persson P.B. The kallikrein-kinin system. Acta Physiologica 2012, 206:215-219.
21. Hirota T., Nonaka A., Matsushita A., Uchida N., Ohki K., Asakura M., Kitakaze M. Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart and Vessels 2011, 26:549-556.
22. Ko S.-C., Kim D.G., Han C.-H., Lee Y.J., Lee J.-K., Byun H.-G., Lee S.-C., Park S.-J., Lee D.-H., Jeon Y.-J. Nitric oxide-mediated vasorelaxation effects of anti-angiotensin I-converting enzyme (ACE) peptide from Styela clava flesh tissue and its anti-hypertensive effect in spontaneously hypertensive rats. Food Chemistry 2012, 134:1141-1145.
23. Kohlstedt K., Busse R., Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 2005, 45:126-132.
24. Kohlstedt K., Trouvain C., Boettger T., Shi L., Fisslthaler B., Fleming I. AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post transcriptional regulation of microRNA-143/145. Circulation Research 2013, 112:1150-1158.
25. Li H., Meininger C.J., Hawker J.R.J.R., Haynes T.E., Kepka-Lenhart D., Mistry S.K., Morris J.R.S.M., Wu G. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. American Journal of Physiology. Endocrinology and Metabolism 2001, 280:E75-E82.
26. Lu J., Sawano Y., Miyakawa T., Xue Y.-L., Cai M.-Y., Egashira Y., Ren D.-F., Tanokura M. One-week antihypertensive effect of Ile-Gln-Pro in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2011, 59:559-563.
27. Marques C., Amorim M.M., Pereira J.O., Pintado M.E., Moura D., Calhau C., Pinheiro H. Bioactive peptides: Are there more antihypertensive mechanisms beyond ACE inhibition?. Current Pharmaceutical Design 2012, 18:4706-4713.
28. Martínez-Maqueda D., Miralles B., Cruz-Huerta E., Recio I. Casein hydrolysate and derived peptides stimulate mucin secretion and gene expression in human intestinal cells. International Dairy Journal 2013, 32:13-19.
29. Martínez-Maqueda D., Miralles B., Recio I., Hernández-Ledesma B. Antihypertensive peptides from food proteins: A review. Food & Function 2012, 3:350-361.
30. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:272-277.
31. McCormick M.E., Goel R., Fulton D., Oess S., Newman D., Tzima E. Platelet-endothelial call adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:643-649.
32. Qian J., Fulton D. Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Frontiers in Physiology 2013, 4:1-11.
33. S2-casein hydrolysates on angiotensin I-converting enzyme in human endothelial cells in vitro, rat aortic tissue ex vivo, and renovascular hypertensive rats in vivo. Journal of Dairy Science 2010, 93:2906-2921.
34. Ruiz-Giménez P., Burguete M.C., Castelló-Ruiz M., Marcos J.F., Salom J.B., Vallés S., Torregrosa G., Alborch E., Manzanares P. Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on angiotensin I-converting enzyme-dependent vasoconstriction. International Dairy Journal 2007, 17:1212-1215.
35. Ruiz-Giménez P., Ibáñez A., Salom J.B., Marcos J.F., López-Díez J.J., Vallés S., Torregrosa G., Alborch E., Manzanares P. Antihypertensive properties of lactoferricin B-derived peptides. Journal of Agricultural and Food Chemistry 2010, 58:6721-6727.
36. Ruiz-Giménez P., Salom J.B., Marcos J.F., Vallés S., Martinez-Maqueda D., Recio I., Torregrosa G., Alborch E., Manzanares P. Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: Identification of novel active peptides. Food Chemistry 2012, 131:266-273.
37. Sánchez D., Kassan M., Contreras M.M., Carrón R., Recio I., Montero M.J., Sevilla M.A. Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefits. Pharmacological Research 2011, 63:398-404.
38. Schmidt H.H.H.W., Lohmann S.L., Walter U. The nitric oxide and cGMP signal-transduction pathway. Biochimica et Biophysica Acta 1993, 1178:153-175.
39. Sentandreu M.A., Toldrá F. A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme. Food Chemistry 2006, 97:546-554.
40. Sessa W.C. eNOS at a glance. Journal of Cell Science 2004, 117:2427-2429.
41. Shimizu K., Sato M., Zhang Y., Kouguchi T., Takahata Y., Morimatsu F., Shimizu M. The bioavailable octapeptide Gly-Ala-Hyp-Gly-Leu-Hyp-Gly-Pro stimulates nitric oxide synthesis in vascular endothelial cells. Journal of Agricultural and Food Chemistry 2010, 58:6960-6965.
42. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. Journal of Chromatography B 2007, 851:51-70.
43. Udenigwe C.C., Lin Y.S., Hou W.C., Aluko R.E. Kinetics of inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. Journal of Functional Foods 2009, 1:199-207.
44. Udenigwe C.C., Mohan A. Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition. Journal of Functional Foods 2014, 8C:45-52.
45. Vazeux G., Cotton J., Cuniasse P., Dive V. Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme. Biochemical Pharmacology 2001, 61:835-841.
46. Wang X., Wang L., Cheng X., Zhou J., Tang X., Mao X.Y. Hypertension-attenuating effect of whey protein hydrolysate on spontaneously hypertensive rats. Food Chemistry 2012, 134:122-126.
47. Yamaguchi N., Kawaguchi K., Yamamoto N. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. European Journal of Pharmacology 2009, 620:71-77.
48. Yang H.Y., Yang S.C., Chen J.R., Tzeng Y.H., Han B.C. Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. The British Journal of Nutrition 2004, 92:507-512.
49. Yu Z., Yin Y., Zhao W., Chen F., Liu J. Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the renin-angiotensin system. Journal of Agricultural and Food Chemistry 2014, 62:912-917.
50. Zabel U., Weeger M., La M., Schmidt H.H.H.W. Human soluble guanylate cyclase: Functional expression and revised isoenzyme family. The Biochemical Journal 1998, 335:51-57.
51. Zimmermann K., Opitz N., Dedio J., Renné C., Müller-Esterl W., Oess S. NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:17167-17172.